Related Experiment Video
Updated: Dec 3, 2025
10:39
3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache
Published on: June 2, 2014
18.6K
Statin for Migraine Headache: Is It Worthwhile?
Mehdi Sayyah1, Kiarash Shirbandi2, Fakher Rahim3
1Faculty Member of Education Development Center, Psychiatrist, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
Neurology India
|October 28, 2020
Summary
Statins, known for cholesterol management, show promise for treating migraine headaches, especially in patients unresponsive to standard therapies. Further research may establish statins as a novel option for migraine prevention and treatment.
Area of Science:
- Neurology
- Pharmacology
Background:
- Migraine is a prevalent neurological disorder affecting 12% of the population, characterized by severe headaches and associated symptoms like nausea and photosensitivity.
- Current first-line preventive treatments for migraine include beta-blockers, antidepressants, and anticonvulsants, with calcium channel blockers as alternatives.
Purpose of the Study:
- To explore the potential efficacy of statins in managing migraine headaches.
- To investigate statins as a therapeutic option for patients with migraine who do not respond to conventional preventive treatments.
Main Methods:
- Review of existing epidemiologic, clinical, and experimental evidence on statin effects.
- Focus on studies examining statins' pleiotropic effects beyond cholesterol reduction, such as anti-inflammatory and antioxidant properties.
Main Results:
- Statins possess pleiotropic effects including anti-inflammatory, antioxidant, and immunomodulatory properties, which may be relevant to migraine pathophysiology.
- Preliminary evidence suggests statins could be effective in treating migraine, particularly in refractory cases.
Conclusions:
- Statins represent a novel and promising candidate for the treatment and prophylaxis of migraine.
- Further investigation into statins' role in managing blood lipids and their direct impact on migraine episodes could improve patient quality of life.
Related Concept Videos
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
1.2K
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.2K
01:26Atherosclerosis III: Management
215
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
215
01:25Antianginal Drugs: Calcium Channel Blockers and Ranolazine
1.1K
Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
1.1K
01:26Angina IV: Management
151
IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
151
01:25Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
247
Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
247
01:23Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
336
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
336